| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e6266b3e0867c2f8a7128cd91a12418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3951c01f77506012990588f738a7dcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4242a3e8006d8f193406c5cd3b327066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0136bb206024de847a5974fecd28e2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7c25a41855ccc38dae118470e328952
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90245 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2011-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65476b78f425a0f0ef68303137f632db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41011c804676fe08924486d2aa8aa371
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46540f6966f766a2ff69cd976db80fa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01e3c45bc70454f2ef66b1477774b347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bad8b1894f102a749bd3d45a8ff9c5f7 |
| publicationDate |
2013-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013116343-A1 |
| titleOfInvention |
Salivary Protein Markers for Detection of Breast Cancer |
| abstract |
A method of diagnosing a patient's risk of breast cancer comprises measuring in a saliva sample from the patient a concentration of at least a first protein marker, wherein the first protein marker is either ubiquitin or cytochrome p450, to provide a set of test data comprising a concentration value of each protein marker in the saliva sample. The test values are then compared to a reference panel comprising a Reference Control Value and a Reference Breast Cancer Value, and a diagnosis of either increased or decreased risk of breast cancer is determined for the patient based on a result of that comparison. A test kit for identifying a person at increased risk of breast cancer is also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111323601-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11078256-B2 |
| priorityDate |
2010-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |